• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆新冠肺炎的区域易感性。

Regional vulnerability for COVID-19 in Cameroon.

作者信息

Judson Seth David, Njabo Kevin Yana, Torimiro Judith Ndongo

机构信息

Department of Medicine, University of Washington, Seattle, USA.

Center for Tropical Research, University of California, Los Angeles, USA.

出版信息

Pan Afr Med J. 2020 Sep 23;37(Suppl 1):16. doi: 10.11604/pamj.supp.2020.37.16.26167. eCollection 2020.

DOI:10.11604/pamj.supp.2020.37.16.26167
PMID:33343795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7733345/
Abstract

INTRODUCTION

few studies have assessed risk for coronavirus disease 2019 (COVID-19) within African countries. Here we examine differences in vulnerability to COVID-19 among the ten administrative regions and two major cities of Cameroon based on epidemiological risk factors and access to healthcare resources.

METHODS

regional epidemiological and healthcare access vulnerability indices were created and compared with cumulative COVID-19 cases, case fatality rates, co-morbidities, and healthcare resources in Cameroon.

RESULTS

based on epidemiological risk factors, populations in the East Region, Douala (in the Littoral Region), West Region, and Yaoundé (in the Center Region) are at highest risk for COVID-19. Meanwhile, the North, Far North, East, and Adamawa Regions had the most healthcare access vulnerability. COVID-19 cases per population were highest in the Center, Littoral, and East Regions. Case fatality rates were greatest in the North Region. Potential co-morbidities with greater prevalence among COVID-19 patients included male sex, hypertension, and diabetes.

CONCLUSION

epidemiological risk factors for COVID-19 and access to healthcare varies between the regions of Cameroon. These discrepancies are potentially reflected in regional differences of COVID-19 cases and case fatality rates. In particular, the East Region has high epidemiological risk factors and low healthcare accessibility compared to other regions. Understanding the relationships between epidemiological risk factors, access to healthcare resources, and COVID-19 cases in Cameroon could aid decision-making among national policymakers and inform further research.

摘要

引言

在非洲国家中,很少有研究评估2019冠状病毒病(COVID-19)的风险。在此,我们根据流行病学风险因素和获得医疗资源的情况,研究喀麦隆十个行政区和两个主要城市中对COVID-19易感性的差异。

方法

创建区域流行病学和医疗可及性脆弱性指数,并与喀麦隆的COVID-19累计病例、病死率、合并症和医疗资源进行比较。

结果

基于流行病学风险因素,东部地区、杜阿拉(滨海地区)、西部地区和雅温得(中部地区)的人群感染COVID-19的风险最高。同时,北部、极北、东部和阿达马瓦地区的医疗可及性脆弱性最大。人均COVID-19病例数在中部、滨海和东部地区最高。病死率在北部地区最高。COVID-19患者中患病率较高的潜在合并症包括男性、高血压和糖尿病。

结论

喀麦隆各地区之间COVID-19的流行病学风险因素和获得医疗服务的情况各不相同。这些差异可能反映在COVID-19病例和病死率的区域差异上。特别是,与其他地区相比,东部地区的流行病学风险因素较高,医疗可及性较低。了解喀麦隆流行病学风险因素、获得医疗资源的情况与COVID-19病例之间的关系,有助于国家政策制定者进行决策,并为进一步的研究提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4736/7733345/b3576c6bbe1d/PAMJ-SUPP-37-1-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4736/7733345/b3576c6bbe1d/PAMJ-SUPP-37-1-16-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4736/7733345/b3576c6bbe1d/PAMJ-SUPP-37-1-16-g001.jpg

相似文献

1
Regional vulnerability for COVID-19 in Cameroon.喀麦隆新冠肺炎的区域易感性。
Pan Afr Med J. 2020 Sep 23;37(Suppl 1):16. doi: 10.11604/pamj.supp.2020.37.16.26167. eCollection 2020.
2
Development of a composite scoring system to rank communities at high risk of zero-dose children in Cameroon: A geospatial analysis.开发一种综合评分系统,对喀麦隆零剂量儿童高危社区进行排名:一项地理空间分析。
J Glob Health. 2023 Nov 17;13:04136. doi: 10.7189/jogh.13.04136.
3
Outcome of hospitalized patients with COVID-19 and predictors at the Buea Regional Hospital, South West region of Cameroon.喀麦隆西南部布埃亚地区医院住院 COVID-19 患者的结局和预测因素。
Pan Afr Med J. 2024 Apr 4;47:165. doi: 10.11604/pamj.2024.47.165.34572. eCollection 2024.
4
COVID-19 in WHO African Region: Account and Correlation of Epidemiological Indices with Some Selected Health-related Metrics.世卫组织非洲区域的 COVID-19 疫情:流行病学指标与部分选定卫生相关指标的核算和关联。
Ethiop J Health Sci. 2021 Nov;31(6):1075-1088. doi: 10.4314/ejhs.v31i6.2.
5
Comparative analysis of two molecular tests for the detection of COVID-19 in Cameroon.喀麦隆两种新冠病毒分子检测方法的比较分析。
Pan Afr Med J. 2021 Jul 26;39:214. doi: 10.11604/pamj.2021.39.214.30718. eCollection 2021.
6
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.喀麦隆雅温得:第二波 COVID-19 期间社区 SARS-CoV-2 血清阳性率迅速上升。
Emerg Infect Dis. 2022 Jun;28(6):1233-1236. doi: 10.3201/eid2806.212580. Epub 2022 Apr 26.
7
COVID-19 data reporting systems in Africa reveal insights for future pandemics.非洲的 COVID-19 数据报告系统为未来的大流行提供了洞察。
Epidemiol Infect. 2022 Jun 16;150:e119. doi: 10.1017/S0950268822001054.
8
Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin.评估 COVID-19 疫情对喀麦隆和贝宁最大城市中关键和低危人群中 HIV 产生的潜在影响。
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):899-911. doi: 10.1097/QAI.0000000000002663.
9
COVID-19 in a region of Cameroon hit by armed conflict.喀麦隆受武装冲突影响地区的 COVID-19 疫情。
Pan Afr Med J. 2022 Jan 12;41:32. doi: 10.11604/pamj.2022.41.32.32587. eCollection 2022.
10
Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon.喀麦隆杜阿拉拉昆蒂尼医院 COVID-19 患者院内全因死亡率的预测因素。
Travel Med Infect Dis. 2022 May-Jun;47:102292. doi: 10.1016/j.tmaid.2022.102292. Epub 2022 Mar 18.

引用本文的文献

1
Biological profile and risk factors of mortality in COVID-19 patients at Adlucem hospital in Banka-Bafang, Cameroon: a cross-sectional study.喀麦隆班卡-巴方阿德卢塞姆医院新冠肺炎患者的生物学特征及死亡风险因素:一项横断面研究
BMC Infect Dis. 2025 Mar 26;25(1):420. doi: 10.1186/s12879-025-10845-2.
2
SARS-CoV-2 active infection and antibodies amongst health personnel during the outbreak in Cameroon: Strengthening the health system for response to future public health emergencies.在喀麦隆疫情期间卫生人员中的 SARS-CoV-2 活性感染和抗体:加强卫生系统以应对未来的突发公共卫生事件。
PLoS One. 2024 May 31;19(5):e0304477. doi: 10.1371/journal.pone.0304477. eCollection 2024.
3

本文引用的文献

1
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy.接受抗逆转录病毒治疗的HIV阳性者中COVID-19的发病率和严重程度。
Ann Intern Med. 2021 Apr;174(4):581-582. doi: 10.7326/L20-1399.
2
COVID-19: challenges and the impact on care in clinical settings in Cameroon.新冠疫情:喀麦隆临床环境中面临的挑战及其对医疗护理的影响
Pan Afr Med J. 2020 Jul 24;35(Suppl 2):122. doi: 10.11604/pamj.supp.2020.35.24929. eCollection 2020.
3
Global and Temporal COVID-19 Risk Evaluation.全球及时间维度的 COVID-19 风险评估
An early warning precision public health approach for assessing COVID-19 vulnerability in the UK: the Moore-Hill Vulnerability Index (MHVI).
一种用于评估英国 COVID-19 脆弱性的早期预警精准公共卫生方法:摩尔-希尔脆弱性指数(MHVI)。
BMC Public Health. 2023 Nov 2;23(1):2147. doi: 10.1186/s12889-023-17092-7.
4
Face mask ownership/utilisation and COVID-19 vaccine hesitancy amongst patients recovering from COVID-19 in Cameroon: A cross-sectional study.《喀麦隆 COVID-19 康复患者的口罩拥有/使用情况与 COVID-19 疫苗犹豫:一项横断面研究》。
PLoS One. 2023 Jan 20;18(1):e0280269. doi: 10.1371/journal.pone.0280269. eCollection 2023.
5
COVID-19 perceptions and vaccine hesitancy: Acceptance, attitude, and barriers among Cameroonians.COVID-19 认知和疫苗犹豫:喀麦隆人的接受程度、态度和障碍。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1823-1829. doi: 10.1016/j.japh.2022.07.002. Epub 2022 Jul 12.
6
SARS-CoV-2, HIV, and triple co-infection.严重急性呼吸综合征冠状病毒2型、人类免疫缺陷病毒与三重合并感染
Clin Case Rep. 2022 Jul 14;10(7):e6018. doi: 10.1002/ccr3.6018. eCollection 2022 Jul.
7
COVID-19 data reporting systems in Africa reveal insights for future pandemics.非洲的 COVID-19 数据报告系统为未来的大流行提供了洞察。
Epidemiol Infect. 2022 Jun 16;150:e119. doi: 10.1017/S0950268822001054.
8
Reach and Utility of COVID-19 Information and Preventive Measures for Nomadic Populations in Massangam, West Region of Cameroon.喀麦隆西部地区马桑甘姆游牧人口的新冠疫情信息及预防措施的可及性与实用性
Am J Trop Med Hyg. 2022 Mar 2;106(5):1491-7. doi: 10.4269/ajtmh.21-0792.
9
Neurological manifestations in patients with symptomatic COVID-19 admitted to the Bafoussam Regional Hospital, Cameroon.喀麦隆巴富萨姆地区医院收治的有症状 COVID-19 患者的神经表现。
Pan Afr Med J. 2021 Apr 5;38:326. doi: 10.11604/pamj.2021.38.326.28973. eCollection 2021.
10
COVID-19 Preventive Behaviours in Cameroon: A Six-Month Online National Survey.喀麦隆的 COVID-19 预防行为:一项为期六个月的全国在线调查。
Int J Environ Res Public Health. 2021 Mar 4;18(5):2554. doi: 10.3390/ijerph18052554.
Front Public Health. 2020 Aug 7;8:440. doi: 10.3389/fpubh.2020.00440. eCollection 2020.
4
A vulnerability index for COVID-19: spatial analysis at the subnational level in Kenya.COVID-19 脆弱性指数:肯尼亚国家以下层面的空间分析。
BMJ Glob Health. 2020 Aug;5(8). doi: 10.1136/bmjgh-2020-003014.
5
A vulnerability index for the management of and response to the COVID-19 epidemic in India: an ecological study.印度 COVID-19 疫情管理和应对的脆弱性指数:一项生态学研究。
Lancet Glob Health. 2020 Sep;8(9):e1142-e1151. doi: 10.1016/S2214-109X(20)30300-4. Epub 2020 Jul 16.
6
COVID-19 in Cameroon: a crucial equation to resolve.喀麦隆的新冠肺炎疫情:一个亟待解决的关键问题。
Lancet Infect Dis. 2020 Dec;20(12):1367-1368. doi: 10.1016/S1473-3099(20)30373-X. Epub 2020 May 6.
7
Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.2019 年冠状病毒和人类免疫缺陷病毒感染者:纽约市住院患者的结局。
Clin Infect Dis. 2020 Dec 31;71(11):2933-2938. doi: 10.1093/cid/ciaa880.
8
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.2020 年,由于潜在健康状况,全球、区域和国家估计有多少人面临 COVID-19 重症风险增加:一项建模研究。
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017. doi: 10.1016/S2214-109X(20)30264-3. Epub 2020 Jun 15.
9
COVID-19 Across Africa: Epidemiologic Heterogeneity and Necessity of Contextually Relevant Transmission Models and Intervention Strategies.非洲的 COVID-19 疫情:流行病学异质性与建立具有本土特色的传播模型和干预策略的必要性。
Ann Intern Med. 2020 Nov 3;173(9):752-753. doi: 10.7326/M20-2628. Epub 2020 Jun 18.
10
A framework for nosocomial transmission of emerging coronaviruses.
Infect Control Hosp Epidemiol. 2021 May;42(5):639-641. doi: 10.1017/ice.2020.296. Epub 2020 Jun 11.